Healthcare Industry News: Alaris
News Release - September 18, 2009
Cardinal Health Licenses Tillotson Patent for Nitrile GlovesLEXINGTON, MA - (HSMN NewsFeed) - Tillotson Corp. today announced that Cardinal Health has licensed a Tillotson U.S. patent for disposable Nitrile Gloves.
"We are very pleased to have Cardinal Health join almost three dozen U.S. and international licensees of our patent," said Tillotson Vice President Rick Tillotson. Terms of the agreement were not disclosed.
Neil Tillotson and Luc DeBecker developed and patented the Nitrile glove technology in 1990. The Tillotson patent covers technology related to the production of a synthetic rubber glove that relaxes after being donned and comfortably conforms to the contours of the wearer's hand. The patent was reissued in 1997.
About Tillotson Corporation
Tillotson Corporation was started by Neil Tillotson, after selling his new invention, the world's first latex balloons, at the Patriot's Day Parade in 1931.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE:CAH ) is a $91 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris IV pumps, Pyxis automated dispensing and patient identification systems, MedMined(TM) electronic infection surveillance service and VIASYS respiratory care products. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 18 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at www.cardinalhealth.com.
Source: Tillotson Corp
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.